Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open-label trial. (2023)

First Author: Wajja A

Attributed to: Immunomodulation and Vaccines funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(23)00501-7

PubMed Identifier: 38012890

Publication URI: http://europepmc.org/abstract/MED/38012890

Type: Journal Article/Review

Parent Publication: The Lancet. Infectious diseases

ISSN: 1473-3099